Study Name: Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)
28 locations found
- GSK Investigational Site
Location: New Haven, Connecticut 06520
- GSK Investigational Site
Location: Bethesda, Maryland 20892
- GSK Investigational Site
Location: Boston, Massachusetts 02115
- GSK Investigational Site
Location: Brookline, Massachusetts 02445
- GSK Investigational Site
Location: New York, New York 10029
- GSK Investigational Site
Location: Chapel Hill, North Carolina 27599
- GSK Investigational Site
Location: Pittsburgh, Pennsylvania 15213
- GSK Investigational Site
Location: Richmond, Virginia 23298
- GSK Investigational Site
Location: Anchorage, Alaska 99508
- GSK Investigational Site
Location: San Diego, California 92111
- GSK Investigational Site
Location: Denver, Colorado 80206
- GSK Investigational Site
Location: Port St. Lucie, Florida 34952
- GSK Investigational Site
Location: Ames, Iowa 50010
- GSK Investigational Site
Location: Grand Rapids, Michigan 49546
- GSK Investigational Site
Location: Southfield, Michigan 48075
- GSK Investigational Site
Location: Rochester, Minnesota 55905
- GSK Investigational Site
Location: Chesterfield, Missouri 63017
- GSK Investigational Site
Location: Fargo, North Dakota 58122
- GSK Investigational Site
Location: Cincinnati, Ohio 45229
- GSK Investigational Site
Location: Cleveland, Ohio 44195
- GSK Investigational Site
Location: Columbus, Ohio 43219
- GSK Investigational Site
Location: South Euclid, Ohio 44121
- GSK Investigational Site
Location: Oklahoma City, Oklahoma 73112
- GSK Investigational Site
Location: Weatherford, Oklahoma 73096
- GSK Investigational Site
Location: Greenville, South Carolina 29615
- GSK Investigational Site
Location: Houston, Texas 77030
- GSK Investigational Site
Location: Salt Lake City, Utah 84132
- GSK Investigational Site
Location: Madison, Wisconsin 53717
|